Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318) Marża Operacyjna

Q: Jaka jest cena za Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318)

Cena za Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318) wynosi $0.7463065

Q: Jaka jest kapitalizacja rynkowa dla Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318)

Kapitalizacja rynkowa dla Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318) wynosi $609.66M

Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a Chinese enterprise that manages the full spectrum of diagnostic product operations, from initial research and development through manufacturing, sales, and post-sale support. Their offerings include a variety of diagnostic tools such as the GenPlex microfluidic automated system for nucleic acid detection, immunofluorescence detection solutions, and products for analyzing human trace elements. Additionally, the company provides advanced chemical analysis instrumentation, featuring atomic fluorescence spectrometers, photometers, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, and ICP spectroscopy equipment, along with vital consumables for life sciences. Founded in 2001, the company is headquartered in Beijing, China. It adopted its current name, Beijing Bohui Innovation Biotechnology Group Co., Ltd., in August 2021, having previously been known as Beijing Bohui Innovation Biotechnology Co., Ltd.

Rok	Marża operacyjna	Zmień
Za mało danych dla podanych dat.

Rok

Marża operacyjna

Zmień

Za mało danych dla podanych dat.

Firma	Marża operacyjna	Różnica w marży operacyjnej	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	38.59%	-	US
Argenx SE ARGX.US	28.81%	-	NL
CSL Limited CSL.AX	25.72%	-	AU
Moderna, Inc. MRNA.US	-149.01%	-	US
Lonza Group AG LONN.SW	0.00%	-	CH

Firma

Marża operacyjna

Różnica w marży operacyjnej

Kraj